Cipher Pharmaceuticals says Absorica acne drug gets FDA approval, shares soar – proactiveinvestors.com

The company’s first product is a fenofibrate formulation marketed in the United States as Lipofen, used to treat high cholesterol. Its second product is an extended-release tramadol that is marketed in the US as ConZip, and is marketed in Canada as Durela …

Posted in Uncategorized